Intact, 45‐kDa (membrane) form of CD23 is consistently mitogenic for normal and transformed B lymphoblasts
- 1 March 1990
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 20 (3) , 539-543
- https://doi.org/10.1002/eji.1830200312
Abstract
When isolated from lysates of the RPMI 8866 B lymphoblastoid cell line, the CD23 antigen was found to be present in two forms corresponding to the intact 45-kDa membrane species and to a 25-kDa product that is more usually found as a released fragment in the extracellular medium. By contrast with preparations of extracellular species of CD23 which were seen to be variable in their biological activity, cell-associated CD23 was consistently mitogenic both for autogenous transformed B lymphoblasts and for pre-activated normal B cells. Addition to the normal cocktail of protease inhibitors in N.alpha.-tosyl-L-lysine chloromethylketone (TLCK), which has selectivity for trypsin-like serine proteases, resulted in preparations of CD23 from RPMI 8866 cell lysates that were exclusively in the 45-kDa intact form; such material retained full and reliable activity in the biological assays. The implications of these observations for the autocrine control of B lymphocyte growth are discussed.This publication has 28 references indexed in Scilit:
- Membrane-anchored growth factors work!Trends in Biochemical Sciences, 1989
- Regulation by interleukin 2 of CD23 expression of leukemic and normal B cells: comparison with interleukin 4European Journal of Immunology, 1989
- Human IgE-binding factorsImmunology Today, 1989
- CD23: a multi-functional receptor/ lymphokine?Immunology Today, 1989
- Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes.The Journal of Experimental Medicine, 1987
- Molecular structure of human lymphocyte receptor for immunoglobulin ECell, 1986
- From parasites to allergy: a second receptor for IgEImmunology Today, 1986
- Evidence for an association between CD23 and the receptor for a low molecular weight B cell growth factorEuropean Journal of Immunology, 1986
- Early events in Epstein-Barr virus infection provide a model for B cell activation.The Journal of Experimental Medicine, 1985
- Immortalized B lymphocytes produce B-cell growth factorNature, 1984